In 2018, Li et al. demonstrated that Sema4D is highly expressed in gastric carcinoma tissues, and its levels were significantly associated with the histological subtype, TMN stage, and lymph node metastasis. Here, SEMA4D is linked to metastatic malignant neoplasm in the lymph nodes.